Tetrahydronaphthyl azole oxime ethers: The conformationally rigid analogues of oxiconazole as antibacterials

European Journal of Medicinal Chemistry

Volumn 44, Issue 1, 2009, Pages 437-447

  Bhandari, Kalpana ^a   Srinivas, Nagarapu ^a   Shiva Keshava, G B ^a   Shukla, Praveen K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antibacterial activity; Antimicrobials; Oxiconazole; Rigid analogues; Tetrahydronaphthyl oxime ethers

Indexed keywords

2 IMIDAZOL 1 YLMETHYL 3,4 DIHYDRO 2H NAPHTHALEN 1 ONE O (3 CHLORO BENZYL) OXIME; 2 IMIDAZOL 1 YLMETHYL 5 METHYL 3,4 DIHYDRO 2H NAPHTHALEN 1 ONE O (3 CHLOROBENZYL) OXIME; 2 IMIDAZOL 1 YLMETHYL 5 METHYL 3,4 DIHYDRO 2H NAPHTHALEN 1 ONE O BENZYL OXIME; 5 BROMO 2 (1,2,4) TRIAZOL 1 YLMETHYL 3,4 DIHYDRO 2H NAPHTHALEN 1-ONE O (3 CHLOROBENZYL) OXIME; 5 BROMO 2 IMIDAZOL 1 YLMETHYL 3,4 DIHYDRO 2H NAPHTHALEN 1 ONE O (3 CHLOROBENZYL) OXIME; 5 BROMO 2 IMIDAZOL 1 YLMETHYL 3,4 DIHYDRO 2H NAPHTHALEN 1 ONE O BENZYL OXIME; 5 CHLORO 2 IMIDAZOL 1 YLMETHYL 3,4 DIHYDRO 2H NAPHTHALEN 1 ONE O BENZYL OXIME; 5 FLUORO 2 IMIDAZOL 1 YLMETHYL 3,4 DIHYDRO 2H NAPHTHALEN 1 ONE O (3 CHLOROBENZYL) OXIME; FLUCONAZOLE; GENTAMICIN; MICONAZOLE; OXICONAZOLE; PYRROLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG CONFORMATION; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; AZOLES; BACTERIA; ESCHERICHIA COLI; ETHERS; IMIDAZOLES; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR CONFORMATION; NAPHTHALENES; OXIMES; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 57949088645     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.01.006     Document Type: Article

References (26)

1. Abbanat D., Macielag M., and Bush K. Expert Opin. Investig. Drugs 12 (2003) 379
2. Pootoolal J., Neu J., and Wright G.D. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 381
3. Raad I.I., Hanna H.A., Hachem R.Y., Dvorak T., Arbuckle R.B., Chaiban G., and Rice R.B. Antimicrob. Agents Chemother. 48 (2004) 3583
4. Goldstein F.W. Clin. Microbiol. Infect. 13 s2 (2007) 2-6
5. Fidler D.F. Emerg. Infect. Dis. 4 (1998) 169-177
6. Macchiarulo A., Constantino G., Fringuelli D., Vecchiarelli A., Schiaffella F., and Fringuelli R. Bioorg. Med. Chem. 10 (2002) 3415-3423
7. Sheehan D.J., Hitchcock C.A., and Sibley C.M. Clin. Microbiol. Rev. 12 (1999) 40-79
8. Lovey R.G., Elliott A.J., Kaminski J.J., Loebenberg D., Parmegiani R.M., Rane D.F., Girijavallabhan V.M., Pike R.E., Guzik H., Antonacci B., and Tomaine T.Y. J. Med. Chem. 35 (1992) 4221
9. Bodey G.P. Clin. Infect. Dis. 14 (1992) S161
10. Heerding D.A., Chan G., Walter E.D., Andrew P.F., Janson C.A., Vaidya K.S., Yuan C.K., and Huffman F.W. Bioorg. Med. Chem. Lett. 11 (2001) 2061-2065
11. Heath R.J., and Rock C.O. Nature 406 (2000) 145
12. Ghannoum M.A., and Rice L.B. Clin. Microbiol. Rev. 12 (1999) 501
13. Balkovec J.M. In: Bristol J.A. (Ed). Annual Reports in Medicinal Chemistry vol. 33 (1998), Academic Press, New York 173-182
14. Watkins W.J., and Renau T.E. In: Dohery A.M. (Ed). Annual Reports in Medicinal Chemistry vol. 35 (1999), Academic Press, New York 157-166
15. Rossello A., Bertini S., Lapucci A., Maccia M., Martinelli A., Rapposelli S., Herreos E., and Macchia B. J. Med. Chem. 45 (2002) 4903
16. Krogsgaard-Larsen P., and Bundgaard H. A Textbook of Drug Design and Development (1991), Harwood Academic Publishers, Chur
17. Olson C.E., and Barder A.R. Org. Synth. Coll. Vol. 4 (1963) p. 898
18. Paul C., Alfred R., and Danise C. Bull. Soc. Chim. Fr. 3 (1969) 985-991 (Fr)
19. Baddar F.G., Lanson S., Assal El., and Doss N.A. J. Chem. Soc. (1959) 1027
20. Emami S., Falahati M., Banifatemi A., Moshiri K., and Shafiee A. Arch. Pharm. Pharm. Med. Chem. 335 (2002) 318
21. Emami S., and Shafiee A. Heterocycles 55 (2001) 2059
22. Baji H., Flammang M., Kimny T., Gasques F., Compagnon P.L., and Delcourt A. Eur. J. Med. Chem. 30 (1995) 617
23. National Committee for Clinical Laboratory Standard. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast, Approved Standard. Document M27-A (1997), National Committee for Clinical Laboratory Standards, Wayne, PA
24. National Committee for Clinical Laboratory Standard. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Conidium Forming Lamentous Fungi: Proposed Standard. Document M38-P (1998), National Committee for Clinical Laboratory Standard, Wayne, PA
25. Sud I.J., and Feingold D.S. Antimicrob. Agents Chemother. 22 (1982) 470-474
26. Helmick R.A., Fletcher A.E., Gardner A.M., Gessner C.R., Hvitved A.N., Gustin M.C., and Gardner P.R. Antimicrob. Agents Chemother. 49 (2005) 1837-1843